Cisatracurium Besylate Injection
Product Images NDC 70710-1532

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 70710-1532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 01

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 02

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 03

This text appears to be a collection of percentage values and the letters "HR". It is difficult to determine the context or purpose of these percentages without further information.*

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 04

This is a medication called Cisatracurium besylate Injection that comes in a 5mL single-dose vial. It is usually stored in a temperature range of 2°C to 8°C and should be protected from light. The medication must be used within 21 days of removal from refrigeration in case it is re-refrigerated. The usual dosage and other important information are provided in the package insert. It is made in India and distributed by Zydus Pharmaceuticals in the US. Cisatracurium besylate is a paralyzing agent that can cause respiratory arrest, so facilities for artificial respiration must be available immediately. Each mL of the solution contains 2mg of cisatracurium.*

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 05

This is a warning label for the drug Cisatracurium Besylate, which is a paralyzing agent that is stored refrigerated at 2-8°C to maintain its efficacy. The drug comes in a sterile, intravenous form and should be used within 21 days of refrigeration. If administered incorrectly, it can cause respiratory arrest, so facilities for artificial respiration must be immediately available. The dosage should be determined by a medical professional and is not provided on the label.*

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 06

Cisatracurium Besylate Injection, USP is a medication available in single-dose vials of 10x 5mL and 1x 105mL. The text is partially distorted and incomplete.*

FDA Label Image

226b466f B4db 491d 987d 55a811889f26 07

Cisatracurium Besylate Injection, USP is a medication that comes in a 200 mg/20 mL bottle, with a concentration of 10 mg/mL. Further information is not available due to the lack of readable text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.